101712-01-0

Basic information

• Product Name: 2-Oxazolidinone, 3-[(2S)-2-methyl-1,3-dioxopentyl]-4-(phenylmethyl)-, (4S)-
• CAS NO: 101712-01-0
• Molecular Formula: C16H19NO4
• Molecular Weight: 289.331
• Mol File: 101712-01-0.mol
• Article Data: 11

Chemical Properties

• CAS DataBase Reference: 2-Oxazolidinone, 3-[(2S)-2-methyl-1,3-dioxopentyl]-4-(phenylmethyl)-, (4S)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Oxazolidinone, 3-[(2S)-2-methyl-1,3-dioxopentyl]-4-(phenylmethyl)-, (4S)-(101712-01-0)
• EPA Substance Registry System: 2-Oxazolidinone, 3-[(2S)-2-methyl-1,3-dioxopentyl]-4-(phenylmethyl)-, (4S)-(101712-01-0)

Safety Data

• Hazardous Substances Data: 101712-01-0(Hazardous Substances Data)

Upstream product

• 131685-53-5 (S)-4-benzyl-3-propionyl-2-oxazolidinone 
• 123-38-6 propionaldehyde 
• 124356-91-8 (4R)-3-[(2R,3S)-3-hydroxy-2-methyl-pentanoyl]-4-benzyl-oxazolidine-2-one 
• 101711-78-8 (3R)-3-propionyl-4-benzyloxazolidin-2-one 
• 124356-91-8 (4S,2'S,3'R)-3-(2'-methyl-3'-hydroxypentanoyl)-4-benzyl-2-oxazolidinone 

Downstream Products

• 124356-84-9 <<3-(2R,4R,5S),4R>-3-(5-Hydroxy-2,4,6-trimethyl-1,3-dioxo-hept-6-enyl)-4-(phenylmethyl)>-2-oxazolidinone 
• 124356-84-9 <<3-(2R,4S,5R),4R>-3-(5-Hydroxy-2,4,6-trimethyl-1,3-dioxo-hept-6-enyl)-4-(phenylmethyl)>-2-oxazolidinone 
• 124356-86-1 (2S,4R,5R)-1-((S)-4-Benzyl-2-oxo-oxazolidin-3-yl)-5-hydroxy-2,4-dimethyl-5-phenyl-pentane-1,3-dione 
• 124439-38-9 (2S,4S,5S)-1-((S)-4-Benzyl-2-oxo-oxazolidin-3-yl)-5-hydroxy-2,4-dimethyl-5-phenyl-pentane-1,3-dione 
• 141505-97-7 <<3-(2R,4R,5R),4R>-3-(5-Hydroxy-2,4-dimethyl-1,3-dioxo-heptyl)-4-(phenylmethyl)>-2-oxazolidinone 
• 141505-94-4 (4R)-4-benzyl-3-((2R,4S,5S)-5-hydroxy-2,4-dimethyl-1,3-dioxoheptyl)-2-oxazolidinone 
• 141423-25-8 <<3-(2R,4R,5R,6R,8E),4R>-3-(5-Hydroxy-2,4,6-trimethyl-1,3-dioxo-9-phenyl-8-nonenyl)-4-(phenylmethyl)>-2-oxazolidinone 
• 141423-25-8 <<3-(2R,4S,5S,6R,8E),4R>-3-(5-Hydroxy-2,4,6-trimethyl-1,3-dioxo-9-phenyl-8-nonenyl)-4-(phenylmethyl)>-2-oxazolidinone 
• 124356-83-8 (2S,4R,5S)-1-((S)-4-Benzyl-2-oxo-oxazolidin-3-yl)-5-hydroxy-2,4,6-trimethyl-heptane-1,3-dione 
• 124439-36-7 (2S,4S,5R)-1-((S)-4-Benzyl-2-oxo-oxazolidin-3-yl)-5-hydroxy-2,4,6-trimethyl-heptane-1,3-dione 
• 141505-95-5 <<3-(2R,4R,5R),4R>-3-(5-Hydroxy-2,4,6-trimethyl-1,3-dioxo-heptyl)-4-(phenylmethyl)>-2-oxazolidinone 
• 141505-92-2 <<3-(2R,4S,5S),4R>-3-(5-Hydroxy-2,4,6-trimethyl-1,3-dioxo-heptyl)-4-(phenylmethyl)>-2-oxazolidinone 
• 183960-55-6 (4R)-4-benzyl-3-((2R,4R,5S,6S)-8-bromo-5-hydroxy-2,4,6-trimethyl-1,3-dioxo-8-nonenyl)-2-oxazolidinone 
• 141505-96-6 (2R,4R,5R)-1-((R)-4-Benzyl-2-oxo-oxazolidin-3-yl)-5-hydroxy-2,4,6-trimethyl-hept-6-ene-1,3-dione 

Relevant articles and documents

Studies directed toward synthesis of the structure proposed for stereocalpin A

Some synthetic efforts directed to the proposed structure of stereocalpin A are disclosed. The stereogenic centers in the aldol unit were installed using the method of Evans and the intermediates obtained through a reliable route helped to reveal that the

Biomimetic Synthesis of Lankacidin Antibiotics

We devised short syntheses of lankacidinol and lankacyclinol that feature biomimetic Mannich macrocyclization. The modular construction of the carbon framework of these compounds is amenable to rapid structural diversification for the development of antib

Leiodermatolide derivatives and their use

The present invention refers to leiodermatolide derivatives and the use thereof as cytotoxic agents, in particular in the form of ADC s.

Synthesis, molecular editing, and biological assessment of the potent cytotoxin leiodermatolide

It was by way of total synthesis that the issues concerning the stereostructure of leiodermatolide (1) have recently been solved; with the target now being unambiguously defined, the mission of synthesis changes as to secure a meaningful supply of this ex